xClinical Trials "Driving Manufacturers Overseas"

A study conducted by the US Health Industry Manufacturers Association shows that many device manufacturers who are required to conduct clinical trials before gaining Food and Drug Administration approval for their products are leaving the country. Speedier approval overseas, the long US approval process and Medicare payment issues are contributing to the exodus, it says.

Among the study's findings are that:

- 50% of device manufacturers have already moved some clinical trials of their new product offshore;